Traws Pharma, Inc. · NASDAQ:TRAW

OrbiMed Capital GP VIII LLC bought 597,729 Traws Pharma, Inc. shares (Form 4)

Traded Apr 16, 2026 · Filed Apr 28, 2026

On Apr 16, 2026, OrbiMed Capital GP VIII LLC (10% owner) bought 597,729 Traws Pharma, Inc. shares at US$1.67 for US$998K, leaving 1,203,250 shares. Filed Apr 28, 2026 (Form 4).

Bought
597,729 shares
Price
US$1.67
Value
US$998K
Holding after
1,203,250 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 16, 2026Common StockBuy597,729US$1.671,203,250Indirect

Source

View original at SEC

Related